Question 1

Who are the top researchers at Highlands Oncology Group?

Accepted Answer

Ranked on the quality score, Joseph Thaddeus Beck, Eric Scott Schaefer and Thaddeus Beck lead among researchers whose main affiliation is Highlands Oncology Group.

Question 2

What are the most cited papers from Highlands Oncology Group?

Accepted Answer

The most cited paper from Highlands Oncology Group is "Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer" (José Baselga et al., 2011), with 2,868 citations. Next come "Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer" (876) and "Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years" (656).

Question 3

Which research topics does Highlands Oncology Group publish most on?

Accepted Answer

By volume in 2022-now: Advanced Breast Cancer Therapies, Biological Activity of Diterpenoids and Biflavonoids, Cancer Treatment and Pharmacology and Economic and Financial Impacts of Cancer.

Question 4

Which keywords describe research at Highlands Oncology Group?

Accepted Answer

By fractional works in 2022-now, weighted toward what it does more of than the world: Breast Cancer, Metastatic Breast Cancer, Chemotherapy, Cell Cycle Control, Synthesis, CDK4/6 Inhibitors, Palbociclib and Prognostic Factors.

Question 5

Which fields of science does Highlands Oncology Group work in?

Accepted Answer

In 2022-now, 52% of research at Highlands Oncology Group is in Health Sciences, 20% in Physical Sciences. Its largest fields are Medicine (51%), Biochemistry, Genetics and Molecular Biology (15%), Chemistry (7%). It does 1.8× the world's share of Health Sciences.

Question 6

Is Highlands Oncology Group's research output growing?

Accepted Answer

Output in 2022-2025 was 18% higher than in 2018-2021.